These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29329373)

  • 1. Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?
    Wieland A; Everson GT
    Alcohol Alcohol; 2018 Mar; 53(2):187-192. PubMed ID: 29329373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting.
    Said A; Williams J; Holden J; Remington P; Musat A; Lucey MR
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):928-34. PubMed ID: 15476157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
    Seeff LB; Hoofnagle JH
    Clin Liver Dis; 2003 Feb; 7(1):261-87. PubMed ID: 12691470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
    Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
    World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation.
    Cheong J; Galanko JA; Arora S; Cabezas J; Ndugga NJ; Lucey MR; Hayashi PH; Barritt AS; Bataller R
    Liver Int; 2017 Feb; 37(2):290-298. PubMed ID: 27258535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of hepatitis C-related liver transplantation in direct-acting antiviral era.
    Choudhary NS; Saraf N; Saigal S; Rastogi A; Bhangui P; Thiagrajan S; Soin AS
    Indian J Gastroenterol; 2020 Dec; 39(6):539-543. PubMed ID: 33230754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?
    Dall'Agata M; Gramenzi A; Biselli M; Bernardi M
    World J Gastroenterol; 2014 Jul; 20(28):9253-60. PubMed ID: 25071318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of recurrent HCV infection after liver transplantation].
    Kanizaj TF; Colić-Cvrlje V; Mrzljak A; Ostojić R
    Acta Med Croatica; 2013 Oct; 67(4):373-81. PubMed ID: 24984339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and Post-Transplant Antiviral Therapy (HBV, HCV).
    Welker MW; Zeuzem S
    Visc Med; 2016 Apr; 32(2):105-9. PubMed ID: 27413727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.
    Mutimer DJ; Gunson B; Chen J; Berenguer J; Neuhaus P; Castaing D; Garcia-Valdecasas JC; Salizzoni M; Moreno GE; Mirza D
    Transplantation; 2006 Jan; 81(1):7-14. PubMed ID: 16421468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of recurrent hepatitis C infection after liver transplantation].
    Filipec Kanizaj T; Colić Cvrlje V; Mrzljak A; Ostojić R
    Acta Med Croatica; 2009 Dec; 63(5):451-7. PubMed ID: 20198907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection.
    Krawczyk M; Grat M; Kornasiewicz O; Lewandowski Z; Barski K; Ligocka J; Grat K; Antczak A; Skalski M; Patkowski W; Nyckowski P; Zieniewicz K; Grzelak I; Pawlak J; Alsharabi A; Wróblewski T; Paluszkiewicz R; Najnigier B; Dudek K; Remiszewski P; Smoter P; Grodzicki M; Korba M; Kotulski M; Cieślak B; Kalinowski P; Gierej P; Fraczek M; Rdzanek Ł; Stankiewicz R; Kobryń K; Nazarewski Ł; Giercuszkiewicz D; Piwowarska J; Brudkowska A; Andrzejewska R; Niewiński G; Kilińska B; Zarzycka A; Nowak R; Kosiński C; Korta T; Ołdakowska-Jedynak U; Sańko-Resmer J; Foroncewicz B; Ziółkowski J; Mucha K; Senatorski G; Paczek L; Habior A; Lechowicz R; Polański S; Pacho R; Andrzejewska M; Rowiński O; Kozieł S; Ziarkiewicz-Wróblewska B; Górnicka B; Hevelke P; Cianciara J; Wiercińska-Drapało A; Michałowicz B; Karwowski A; Szczerbań J
    Przegl Epidemiol; 2013; 67(1):5-10, 93-7. PubMed ID: 23745368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.
    Beste LA; Green PK; Berry K; Kogut MJ; Allison SK; Ioannou GN
    J Hepatol; 2017 Jul; 67(1):32-39. PubMed ID: 28267622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes.
    Shen NT; Londono C; Gold S; Wu A; Mages KC; Brown RSJ
    World J Gastroenterol; 2019 Apr; 25(13):1628-1639. PubMed ID: 30983822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.